Positive impactCompany
Chandan Taparia of Motilal Oswal recommends 3 stocks to buy: Laurus Labs, BHEL, HDFC Life; check stop-loss, target price
Livemint 3 hrs ago·18 Sept 2026, 1:13 am
Motilal Oswal analyst Chandan Taparia has included Laurus Labs in his list of recommended stocks for investors to buy. This recommendation comes as part of a broader strategy to identify quality companies with growth potential. For a retail investor, this signals that the brokerage firm sees strong fundamentals and future upside in the company.
The inclusion of Laurus Labs in a 'buy' list is significant because it suggests the analyst believes the stock is currently trading at an attractive valuation or is poised for positive momentum. However, it is important to remember that brokerage recommendations are based on research and market outlooks that can change. Investors should view such advice as information to help with their own analysis rather than a guarantee of profit.
What to watch next involves monitoring the company's quarterly results and the broader pharma sector trends. Investors should also keep an eye on the specific stop-loss and target prices mentioned by the analyst to manage their risk. Always conduct your own due diligence before making any investment decisions.
Affected stocks
Bullish2 stocks
Bull / bear label is derived from the article's AI sentiment — indicative, not advice. Prices may be delayed.
Key takeaways
- Concerns Laurus Labs (LAURUSLABS).
- Category: Company.
- AI reads the tone as positive (potentially bullish) for the stock.
- Also mentions BHEL.
Why it matters
A routine update for Laurus Labs. The tone is positive — historically associated with upward pressure, though not predictive. Use the price and stock snapshot to gauge how the market is responding.
